- Home
- TNC vs NVCR Comparison
TNC vs NVCR Comparison
Compare TNC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNC
- NVCR
- Stock Information
- Founded
- TNC 1870
- NVCR 2000
- Country
- TNC United States
- NVCR Switzerland
- Employees
- TNC N/A
- NVCR N/A
- Industry
- TNC Industrial Machinery/Components
- NVCR Medical/Dental Instruments
- Sector
- TNC Industrials
- NVCR Health Care
- Exchange
- TNC Nasdaq
- NVCR Nasdaq
- Market Cap
- TNC 1.4B
- NVCR 1.9B
- IPO Year
- TNC N/A
- NVCR 2015
- Fundamental
- Price
- TNC $83.65
- NVCR $17.60
- Analyst Decision
- TNC Strong Buy
- NVCR Buy
- Analyst Count
- TNC 1
- NVCR 7
- Target Price
- TNC $125.00
- NVCR $32.43
- AVG Volume (30 Days)
- TNC 148.2K
- NVCR 1.3M
- Earning Date
- TNC 08-07-2025
- NVCR 07-24-2025
- Dividend Yield
- TNC 1.42%
- NVCR N/A
- EPS Growth
- TNC N/A
- NVCR N/A
- EPS
- TNC 3.58
- NVCR N/A
- Revenue
- TNC $1,265,700,000.00
- NVCR $621,711,000.00
- Revenue This Year
- TNC N/A
- NVCR $5.56
- Revenue Next Year
- TNC $4.25
- NVCR $9.19
- P/E Ratio
- TNC $23.34
- NVCR N/A
- Revenue Growth
- TNC 1.35
- NVCR 18.27
- 52 Week Low
- TNC $67.32
- NVCR $14.17
- 52 Week High
- TNC $110.45
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- TNC 70.70
- NVCR 49.74
- Support Level
- TNC $80.70
- NVCR $16.81
- Resistance Level
- TNC $84.98
- NVCR $18.59
- Average True Range (ATR)
- TNC 1.80
- NVCR 0.74
- MACD
- TNC 0.54
- NVCR 0.08
- Stochastic Oscillator
- TNC 87.89
- NVCR 56.18
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.